Résumé
Introduction Self-management interventions show
promising results on symptom outcomes and selfmanagement behaviours. The Symptom Navi©
Programme (SN©P) is a nurse-led intervention supporting
patients’ symptom self-management during anticancer
treatment. It consists of written patient information
(Symptom Navi© Flyers (SN©Flyers)), semistructured
consultations and a training manual for nurses.
Methods and analysis This pilot study will evaluate
the implementation of the SN©P based on the Reach
Effectiveness—Adoption Implementation Maintenance
framework at Swiss outpatient cancer centres. We will
use a cluster-randomised design and randomise the nine
participating centres to the intervention or usual care group.
We expect to include 140 adult cancer patients receiving
first-line systemic anticancer treatment. Trained nurses at the
intervention clusters will provide at least two semistructured
consultations with the involvement of SN©Flyers. Outcomes
include patients’ accrual and retention rates, patient-reported
interference of symptoms with daily functions, symptom
burden, perceived self-efficacy, quality of nursing care,
nurse-reported facilitators and barriers of adopting the
programme, nurses’ fidelity of providing the intervention
as intended, and patients’ safety (patients timely reporting
of severe symptoms). We will use validated questionnaires
for patient-reported outcomes, focus group interviews with
nurses and individual interviews with oncologists. Linear
mixed models will be used to analyse patient-reported
outcomes. Focus group and individual interviews will be
analysed by thematic analysis.
Ethics and dissemination The Symptom Navi© Pilot
Study has been reviewed and approved by Swiss Ethic
Committee Bern (KEK-BE: 2017–00020). Results of the
study will be disseminated in peer-reviewed journal and at
scientific conferences.
Trial registration number NCT03649984; Pre-results.